CHINA STRATEGY
China Entry as a Structural Decision
Structured market entry for regulated industries requiring capital discipline and compliance-first execution.
Regulatory Alignment
Class I–III MedTech and AI/Cloud compliance pathways.
Entity Structuring
WFOE and Joint Venture frameworks.
Execution
Feasibility → Regulatory → Commercial scaling.